Dual Kinase Inhibition of EGFR and HER2 Overcomes Resistance to Cetuximab in a Novel in Vivo Model of Acquired Cetuximab Resistance
Clinical Cancer Research - United States
doi 10.1158/1078-0432.ccr-11-0370
Full Text
Open PDFAbstract
Available in full text
Date
July 26, 2011
Authors
Publisher
American Association for Cancer Research (AACR)